Mr Hayden attended 2 days of learning courtroom skills and presentation of evidence in Manchester. Cross examination by a Bond Solon advocate was an experience to remember.
Jeremy Hayden
Mr Hayden has recently operated on a number of cases of HDGC syndrome where an inherited genetic mutation in CHD-1 (E-cadherin) predisposes to the development of stomach cancer. Affected individuals are recommended to under removal of the whole stomach (total gastrectomy) in order to improve long-term survival and prevent the development of advanced disease. When stomach cancer is caught at an early stage it can be cured.
Jeremy Hayden

April 20, 2017

Partnership with Healthier Weight

Jeremy Hayden Comments are off
In October 2015, Mr Hayden started providing weight loss surgery services for Healthier Weight (www.healthierweight.co.uk) with Specialist Consultations and Surgical Procedures performed at Spire Leeds Hospital. This partnership continues to grow with over 100 procedures performed from customers located in Yorkshire, The North-East of England and Scotland.
Jeremy Hayden

April 30, 2016

Mount Kilimanjaro climbed! Feb 2016

Jeremy Hayden Comments are off
Mr Hayden managed to trek to the summit of Kilimanjaro in Tanzania in February 2016. After 18 months of preparation he managed to raise over £8000 for the Yorkshire Cancer Centre Appeal. It was a physically and emotionally demanding experience that surpassed all expectations.
Jeremy Hayden

May 14, 2015

By-Band-Sleeve Research Study

Jeremy Hayden Comments are off
The randomised-controlled trial of weight loss surgery ‘By-Band’ is funded to include sleeve gastrectomy as the third treatment option and now known as the ‘By-Band-Sleeve’ Trial. Leeds Teaching Hospitals is currently recruiting to this research study.
Jeremy Hayden
I was invited to the January meeting of the Oesophageal Patients Association at Headingley Golf Club a few weeks ago. I met a variety of courageous people who had their disease and its treatment in common. They had all survived and were determined to live a good quality of life and share their experiences with others and learn more about the disease and in particular advances in the treatment. Overall survival from oesophageal cancer is
Jeremy Hayden

November 20, 2014

By-Band Trial Open in Leeds Nov 2014

Jeremy Hayden Comments are off
We are pleased to announce that Leeds Teaching Hospitals has opened recruitment to the By-Band Randomised Controlled Trial. We have managed to recruit our first 3 patients into this important study. Thank you to all members of the teams in Leeds and Bristol for helping to get this off the ground in a relatively short time period.
Jeremy Hayden

July 11, 2014

Trek Kilimanjaro Challenge

Jeremy Hayden Comments are off
I have recently decided to attempt a challenge of a lifetime and trek to the summit of Mount Kilimanjaro, the highest mountain in Africa. It will be a demanding walk spread out over 6-7 days to allow for altitude acclimatisation to try and reach the peak Kibo located 5895 metres (19341 ft) above sea level. I am raising funds for the Yorkshire Cancer Centre Appeal which supports patients with cancer in improving their quality of
Jeremy Hayden
The first meeting tool place in St James’s Institute of Oncology, Leeds on 25th June 2014 to move forward plans to set up enhanced recovery for oesophageal and gastric cancer patients. The meeting was well attended by members of the multidisciplinary team and a overall a positive discussion was achieved. The process aims to improve the experience and outcome for patients who receive an operation to remove this type of cancer. Other units have demonstrated
Jeremy Hayden
I was fortunate to have the opportunity to attend a meeting organised by Jane Blazeby in Bristol yesterday. She has obtained a National Institute for Health Research grant to investigate outcomes of weight loss surgery at 3 years. There is no conclusive good quality evidence to support the benefit of one weight loss surgery operation over another for patients with morbid obesity. This study is known as a ‘randomized-controlled trial’ where those patients who qualify
Jeremy Hayden